On Nov 12, major Wall Street analysts update their ratings for $Fortrea Holdings (FTRE.US)$, with price targets ranging from $25 to $30.
Barclays analyst Luke Sergott maintains with a hold rating, and maintains the target price at $25.
Evercore analyst Elizabeth Anderson CFA maintains with a hold rating, and adjusts the target price from $20 to $25.
TD Cowen analyst Charles Rhyee maintains with a hold rating, and maintains the target price at $25.
Baird analyst Eric Coldwell maintains with a buy rating, and adjusts the target price from $28 to $30.
Furthermore, according to the comprehensive report, the opinions of $Fortrea Holdings (FTRE.US)$'s main analysts recently are as follows:
Following the Q3 report, it's noted that Fortrea experienced a notable increase in bookings, attributed to widespread robustness in biotech and large pharmaceutical companies. This performance is seen as indicative of Fortrea's engagement with market segments that are relatively insulated from the broader biotech funding challenges and major pharmaceutical restructurings.
The firm noted that Fortrea's Q3 results displayed indications of progress, hinting at the company gaining better foresight into its upcoming opportunities.
Expectations are set for exceptional EPS growth and recovery, particularly in the second half of 2025. It is anticipated that the company will successfully navigate TSA and spin transitions at the beginning of 2025, which should lead to a resumption in revenue growth, cost leverage, and reductions in interest expenses.
Here are the latest investment ratings and price targets for $Fortrea Holdings (FTRE.US)$ from 4 analysts:
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.